New study tests laser and PRP boost for acne scar treatment
NCT ID NCT07199608
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares three approaches for treating atrophic acne scars: subcision alone, subcision plus fractional CO2 laser, and subcision plus platelet-rich plasma (PRP). Forty-two adults with mild to severe scars will receive treatment on different sides of the face to see which combination works best. The goal is to find a more effective way to improve scar appearance and patient satisfaction.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- subcision, fractional CO2 laser, platelet-rich plasma (PRP)
- What this could lead to
- If it works, this could point toward a more effective combination treatment for atrophic acne scars, improving appearance and quality of life.
- What could go wrong
- This is a small, early-stage trial with only 42 participants, so results may not apply to everyone. The improvements may be modest and not last long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 42 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Nov 2025
An estimate. Start dates often move.
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * \- Adult patients of both sexes with mild to severe atrophic post-acne scars. Exclusion Criteria: * \- Age \< 18 years * Pregnant or lactating women * Active inflammatory acne or infection in treatment area * Premalignant or malignant lesions * Photosensitive dermatoses * Coagulation defects or blood disease * History of keloid scars * Systemic retinoid use in previous 6 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Atrophic acne scar are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Assiut University Hospitals, Dermatology Department
Asyut, Asyut Governorate, Egypt